UFT and Mitomycin Plus Tamoxifen for Stage II, ER-Positive Breast Cancer
July 1st 1999A trial was designed to examine the combination of UFT and mitomycin (Mutamycin) plus tamoxifen (Nolvadex) as postoperative adjuvant therapy in the treatment of patients with stage II, estrogen receptor (ER)-positive